News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.
The company is positioning the blood-based test as an alternative to invasive chorionic villus sampling, the current standard in Denmark.
The company's test uses self-collected saliva samples from potential parents to assess their future child's genetic predisposition to various diseases.
The firm's revenue decrease was largely driven by a decline in testing volumes due to the COVID-19 pandemic, it said.
Based on 6,447 exome sequences, the researchers estimated that every person is a carrier of at least two pathogenic variants in autosomal-recessive genes.
The deal covers SpeeDx's ResistancePlus and PlexPCR product lines, which include tests for sexually transmitted infections and antibiotic resistance.
